Related Experiment Video
Updated: May 31, 2026

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells
Published on: November 21, 2025
Redox control at the ER-mitochondria interface in kidney transplantation: MAM-centered stress signaling and
Baicheng Kuang1, Lin Han2, Sopheaktra Tan3
1Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Key Laboratory of Organ Transplantation, Ministry of Education, Chinese Academy of Medical Sciences, NHC Key Laboratory of Organ Transplantation, Wuhan, 430030, China; Tongji Junshan Neuroscience Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Abstract:
Kidney transplantation is inevitably accompanied by ischemia-reperfusion injury in which oxidative stress and endoplasmic reticulum (ER) stress act as tightly interconnected drivers of mitochondrial dysfunction, inflammation, and long-term graft failure. Excessive reactive oxygen species disrupt mitochondrial homeostasis, while unresolved ER stress activates maladaptive unfolded protein response signaling, together shaping tubular cell fate. Although these processes have been extensively studied, their spatial and functional integration remains incompletely understood. Growing evidence indicates that oxidative stress and ER stress converge at mitochondria-associated membranes (MAMs), where calcium signaling, redox regulation, and stress-adaptive networks are integrated. However, the dynamic and context-dependent nature of MAM remodeling remains poorly defined and difficult to investigate using conventional experimental systems. In this review, we propose a MAM-centered framework that integrates cellular stress responses, with a particular focus on ischemia-reperfusion in kidney transplantation. We further highlight therapeutic strategies targeting MAM-associated pathways, including mitochondria-directed antioxidants, ER oxidoreductases and structural and signaling proteins of MAM. In parallel, we summarize emerging kidney organoid platforms as human-relevant translational systems for modeling MAM dynamics under controlled conditions. By integrating mechanistic insights with organoid-based investigations, this review bridges a critical gap between molecular understanding and translational application, and offers a conceptual framework for MAM-targeted strategies aimed at improving graft resilience and long-term transplant outcomes.
Insights
Kidney transplant ischemia-reperfusion injury involves oxidative and endoplasmic reticulum (ER) stress. Targeting mitochondria-associated membranes (MAMs) offers a novel strategy to improve kidney graft survival.
Area of Science:
- Nephrology
- Cellular Biology
- Transplantation Immunology
Background:
- Ischemia-reperfusion injury (IRI) is a major cause of kidney transplant failure.
- Oxidative stress and endoplasmic reticulum (ER) stress are key contributors to IRI, driving mitochondrial dysfunction and inflammation.
- The interplay between these stresses and their convergence at mitochondria-associated membranes (MAMs) is not fully understood.
Purpose of the Study:
- To propose a MAM-centered framework integrating cellular stress responses in kidney IRI.
- To highlight therapeutic strategies targeting MAM-associated pathways.
- To discuss kidney organoid platforms for studying MAM dynamics.
Main Methods:
- Review of existing literature on oxidative stress, ER stress, and MAMs in kidney IRI.
- Analysis of therapeutic strategies targeting MAMs.
- Discussion of kidney organoid models for translational research.
Main Results:
- MAMs integrate oxidative and ER stress, influencing mitochondrial function and cell fate.
- Targeting MAM-associated pathways, including antioxidants and ER proteins, shows therapeutic potential.
- Kidney organoids provide a human-relevant model for investigating MAM dynamics.
Conclusions:
- A MAM-centered approach is crucial for understanding and mitigating kidney IRI.
- Targeting MAMs offers promising therapeutic avenues for improving kidney transplant outcomes.
- Organoid platforms facilitate the translation of mechanistic insights into clinical applications.
